Monday, July 09, 2007
Researchers Identify Genetic Mutation That May Alter Patients' Response To Cancer Therapeutics
Researchers Identify Genetic Mutation That May Alter Patients' Response To Cancer Therapeutics: "Researchers from Eli Lilly & Company and the Phoenix-based Translational Genomics Research Institute (TGen) today announced finding a novel recurring mutation of the gene AKT1 in breast, colorectal and ovarian cancers. "
Subscribe to:
Posts
(
Atom
)
Posts
